Viewing Study NCT00381602


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-28 @ 6:14 PM
Study NCT ID: NCT00381602
Status: TERMINATED
Last Update Posted: 2011-04-04
First Post: 2006-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
Sponsor: QLT Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End Stage Renal Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None End stage renal disease View
None Hemodialysis View
None Malnutrition View
None End stage renal disease (ESRD) View